# Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3

> **NCT00812149** · — · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 86 (actual)

## Conditions studied

- Thyroid Disease
- Healthy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00812149
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-17
- **Primary completion:** —
- **Final completion:** 2014-05-16
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812149, "Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00812149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*